Citation Impact
Citing Papers
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
2004 StandoutNobel
Conserved N-terminal cysteine dioxygenases transduce responses to hypoxia in animals and plants
2019 StandoutScienceNobel
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
RGS5, a Hypoxia-inducible Apoptotic Stimulator in Endothelial Cells
2009
Ecological Therapy for Cancer: Defining Tumors Using an Ecosystem Paradigm Suggests New Opportunities for Novel Cancer Treatments
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts
2009 StandoutNobel
Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells
2014
Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors
2010 StandoutNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
A comparison of epithelial-to-mesenchymal transition and re-epithelialization
2012
Tissue‐specific molecular heterogeneity of human growth hormone‐releasing hormone receptor protein
1996
Role of tumor-associated macrophages in tumor progression and invasion
2006
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone‐refractory prostate cancer
2007
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Role of endothelin-1 in osteoblastic bone metastases
2003
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
2014 StandoutNature
Safety and Efficacy of the Specific Endothelin-A Receptor Antagonist ZD4054 in Patients with Hormone-Resistant Prostate Cancer and Bone Metastases Who Were Pain Free or Mildly Symptomatic: A Double-Blind, Placebo-Controlled, Randomised, Phase 2 Trial
2008
The Growth-Hormone-Releasing Hormone Receptor: Signal Transduction, Gene Expression, and Physiological Function in Growth Regulationa
2006
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
HIF-1α in Epidermis: Oxygen Sensing, Cutaneous Angiogenesis, Cancer, and Non-Cancer Disorders
2011
Imaging angiogenesis of genitourinary tumors
2010
Oxygen sensing by HIF hydroxylases
2004 StandoutNobel
Growth Hormone-Releasing Hormone: Synthesis and Signaling
1995
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer
2013
Target cell movement in tumor and cardiovascular diseases based on the epithelial–mesenchymal transition concept
2011
Immunity, Inflammation, and Cancer
2010 Standout
Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection
2015
Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing
2008
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
EMT, the cytoskeleton, and cancer cell invasion
2009
Emerging Biological Principles of Metastasis
2017 Standout
Nicotine and pathological angiogenesis
2012
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
EMT: 2016
2016 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Eicosanoids and cancer
2010 Standout
F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check
2015
Microenvironmental regulation of metastasis
2008 Standout
The Dwarfs of Sindh: severe growth hormone (GH) deficiency caused by a mutation in the GH‐releasing hormone receptor gene
1997
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function
1993
The parallel lives of angiogenesis and immunosuppression: cancer and other tales
2011
Clonal evolution in cancer
2012 StandoutNature
Lectin Galactoside-binding Soluble 3 Binding Protein (LGALS3BP) Is a Tumor-associated Immunomodulatory Ligand for CD33-related Siglecs
2014
Mechanisms of Bone Metastasis
2004 Standout
The Hallmarks of Aging
2013 Standout
G protein-coupled receptors: novel targets for drug discovery in cancer
2010
Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment
2013
Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
2008 StandoutNobel
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
2007
Cancer-related inflammation
2008 StandoutNature
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Endothelin-2 is a macrophage chemoattractant: implications for macrophage distribution in tumors
2002
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
2006 Standout
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
Integration of Oxygen Signaling at the Consensus HRE
2005
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Targeted therapies in control of EMT in carcinoma and fibrosis
2007
β-Arrestin Deficiency Protects Against Pulmonary Fibrosis in Mice and Prevents Fibroblast Invasion of Extracellular Matrix
2011 StandoutNobel
Role of insulin-like growth factors in embryonic and postnatal growth
1993 Standout
A comprehensive pathway map of epidermal growth factor receptor signaling
2005
Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues
2004
Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth.
2003
Integrin-linked kinase – essential roles in physiology and cancer biology
2008
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Emerging Targets in Photopharmacology
2016 StandoutNobel
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Chromatin Immunoprecipitation-Based Screen To Identify Functional Genomic Binding Sites for Sequence-Specific Transactivators
2005
Works of Anna Bagnato being referenced
Endothelin-1 Stimulates Lymphatic Endothelial Cells and Lymphatic Vessels to Grow and Invade
2009
Endothelin-1 Promotes Epithelial-to-Mesenchymal Transition in Human Ovarian Cancer Cells
2005
Inhibition of Tumor Growth and Angiogenesis by SP-2, an Anti–Lectin, Galactoside-Binding Soluble 3 Binding Protein (LGALS3BP) Antibody
2014
Endothelin-1 and Endothelin-3 Promote Invasive Behavior via Hypoxia-Inducible Factor-1α in Human Melanoma Cells
2007
Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells
2011
Endothelin-1 Induces Vascular Endothelial Growth Factor by Increasing Hypoxia-inducible Factor-1α in Ovarian Carcinoma Cells
2002
The endothelin axis in cancer
2008
Endothelin-1 Induces an Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo
2000
Endothelin receptors as novel targets in tumor therapy
2004
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis
2012
Endothelin-1 Protects Ovarian Carcinoma Cells against Paclitaxel-Induced Apoptosis: Requirement for Akt Activation
2002
Targeting Endothelin Axis in Cancer
2006
Emerging role of the endothelin axis in ovarian tumor progression
2005
Endothelin 1 in cancer: biological implications and therapeutic opportunities
2013
Expression of the growth hormone-releasing hormone gene and its peptide product in the rat ovary.
1992
Endothelin-1-induced Prostaglandin E2-EP2, EP4 Signaling Regulates Vascular Endothelial Growth Factor Production and Ovarian Carcinoma Cell Invasion
2004
The endothelin axis: emerging role in cancer
2003
Epithelial-Mesenchymal Transition in Ovarian Cancer Progression: A Crucial Role for the Endothelin Axis
2007
Receptor-Mediated Actions of Growth Hormone Releasing Factor on Granulosa Cell Differentiation
1990
Convergent pathways link the endothelin A receptor to the β-catenin: The β-arrestin connection
2009
Therapeutic targeting of the endothelin a receptor in human ovarian carcinoma.
2003
Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.
2001
β-Arrestin links endothelin A receptor to β-catenin signaling to induce ovarian cancer cell invasion and metastasis
2009
Combined Targeting of Endothelin A Receptor and Epidermal Growth Factor Receptor in Ovarian Cancer Shows Enhanced Antitumor Activity
2007
Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth.
1999
Endothelin-1 Decreases Gap Junctional Intercellular Communication by Inducing Phosphorylation of Connexin 43 in Human Ovarian Carcinoma Cells
2003
Endothelin-1 promotes proteolytic activity of ovarian carcinoma
2002
Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression.
2006
Expression of the growth hormone-releasing hormone gene and its peptide product in the rat ovary
1992
The importance of endothelin axis in initiation, progression, and therapy of ovarian cancer
2010
Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
2000
Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma
2006
ZD4054, a specific antagonist of the endothelin A receptor, inhibits tumor growth and enhances paclitaxel activity in human ovarian carcinoma in vitro and in vivo
2007